Merck and Transcenta partner to advance continuous manufacturing for protein biotherapeutics
Merck and Transcenta have announced a new strategic collaboration this month to implement continuous manufacturing for protein therapeutics.
Archives for December 2, 2020
Preparing for the pivot to downstream continuous processing
Upstream processes were the focus of most early applications of continuous bioprocessing. That is now changing, with many biologic manufacturers evaluating downstream continuous processing and suppliers preparing their portfolios for the anticipated...
Special Edition: The Future of Continuous BioProcessing
Erbi Biosystems’ platform is designed to support continuous processing, and startup flags its potential to transform CAR-T and other autologous therapies
Erbi Biosystems recently raised US$3.8m in a round led by Jaguar Biotech; the funds will allow the company to expand its platform of microfluidic bioprocess and bioreactor equipment, which is said to enable ultra-high cell density and continuous processing.
Special Edition: The Future of Continuous BioProcessing
Addressing barriers to the shift to downstream continuous processing
The shift away from batch downstream processing has moved closer in recent years amid progress on techniques such as antibody purification using continuous chromatography media. However, there remain barriers to clear before manufacturing facilities that...
Pfizer and BioNTech COVID-19 vaccine authorized for use in the UK
The Medicines & Healthcare Products Regulatory Agency (MHRA) in the UK has granted a temporary authorization for emergency use for Pfizer and BioNTech's mRNA vaccine (BNT162b2), against COVID-19.